These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12927591)

  • 1. The differential expression of cytosolic carbonic anhydrase in human hepatocellular carcinoma.
    Kuo WH; Chiang WL; Yang SF; Yeh KT; Yeh CM; Hsieh YS; Chu SC
    Life Sci; 2003 Sep; 73(17):2211-23. PubMed ID: 12927591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma.
    Thasler WE; Schlott T; Thelen P; Hellerbrand C; Bataille F; Lichtenauer M; Schlitt HJ; Jauch KW; Weiss TS
    Histopathology; 2005 Jul; 47(1):57-66. PubMed ID: 15982324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-derived trypsin enhances proliferation of intrahepatic cholangiocarcinoma cells by activating protease-activated receptor-2.
    Nakanuma S; Tajima H; Okamoto K; Hayashi H; Nakagawara H; Onishi I; Takamura H; Kitagawa H; Fushida S; Tani T; Fujimura T; Kayahara M; Ohta T; Wakayama T; Iseki S; Harada S
    Int J Oncol; 2010 Apr; 36(4):793-800. PubMed ID: 20198321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of BCL-2 messenger RNA detected by in situ hybridization in human hepatocellular and cholangiocellular carcinomas.
    Fiorentino M; D'Errico A; Altimari A; Barozzi C; Grigioni WF
    Diagn Mol Pathol; 1999 Dec; 8(4):189-94. PubMed ID: 10617275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.
    Somorácz A; Tátrai P; Horváth G; Kiss A; Kupcsulik P; Kovalszky I; Schaff Z
    Hum Pathol; 2010 Sep; 41(9):1310-9. PubMed ID: 20471664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
    Huang WJ; Jeng YM; Lai HS; Fong IU; Sheu FY; Lai PL; Yuan RH
    PLoS One; 2015; 10(3):e0119181. PubMed ID: 25738958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separate histogenesis of combined hepatocellular and cholangiocellular carcinoma in two patients.
    Nagafuchi Y; Okamoto K; Shono M; Higure A; Todoroki H; Itoh H; Takeda S; Katumoto F; Toyoshima S
    Hepatogastroenterology; 1998; 45(20):523-7. PubMed ID: 9638442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study.
    Zhao Q; Yu WL; Lu XY; Dong H; Gu YJ; Sheng X; Cong WM; Wu MC
    Chin J Cancer; 2016 Aug; 35(1):82. PubMed ID: 27552844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathological significance of the expression of carbonic anhydrase I and II in human pancreatic cancer].
    Sheng WW; Dong M; Zhou JP; Kong FM; Li YJ
    Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(48):3407-11. PubMed ID: 23327700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
    Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
    Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.
    Lee JH; Chung GE; Yu SJ; Hwang SY; Kim JS; Kim HY; Yoon JH; Lee HS; Yi NJ; Suh KS; Lee KU; Jang JJ; Kim YJ
    J Clin Gastroenterol; 2011 Jan; 45(1):69-75. PubMed ID: 20142755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of Bmi1 in hepatocellular carcinoma with bile duct tumor thrombi.
    Zhang R; Xu LB; Zeng H; Yu XH; Wang J; Liu C
    Hepatogastroenterology; 2013; 60(128):2042-7. PubMed ID: 24719948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
    Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
    Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical study of HBV antigens in 338 liver cell carcinomas.
    Herrmann G
    Z Gastroenterol; 1999 May; 37(5):329-42. PubMed ID: 10413841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a new rat cell line established from 2'AAF-induced combined hepatocellular cholangiocellular carcinoma.
    Gil-Benso R; Martinez-Lorente A; Pellin-Perez A; Navarro-Fos S; Gregori-Romero MA; Carda C; Callaghan R; Peydro-Olaya A; Llombart-Bosch A
    In Vitro Cell Dev Biol Anim; 2001 Jan; 37(1):17-25. PubMed ID: 11249201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma.
    Batmunkh E; Tátrai P; Szabó E; Lódi C; Holczbauer A; Páska C; Kupcsulik P; Kiss A; Schaff Z; Kovalszky I
    Hum Pathol; 2007 Oct; 38(10):1508-15. PubMed ID: 17640714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunohistochemical survey of amylase isoenzymes in cholangiocarcinoma and hepatocellular carcinoma.
    Terada T; Nakanuma Y
    Arch Pathol Lab Med; 1993 Feb; 117(2):160-2. PubMed ID: 8381270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined hepatocellular and cholangiocellular carcinoma in a dog.
    Shiga A; Shirota K; Enomoto M
    J Vet Med Sci; 2001 Apr; 63(4):483-6. PubMed ID: 11346190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of anterior gradient protein 3 in intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
    Brychtova V; Zampachova V; Hrstka R; Fabian P; Novak J; Hermanova M; Vojtesek B
    Exp Mol Pathol; 2014 Jun; 96(3):375-81. PubMed ID: 24747240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.